Biotechnology
The Biotechnology industry has a total of 595 stocks, with a combined market cap of $1.3 trillion and total revenue of $115.76 billion.
Market Cap
1.3T
Revenue
115.76B
Profits
-39.65B
PE Ratio
n/a
Profit Margin
-34.25%
Dividend Yield
0.04%
595 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 130.01B | 1.42% | 156,900 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 80.77B | 0.67% | 143,937 | 15.53B |
| 3 | ARGX | argenx SE | 52.87B | 16.39% | 226,254 | 5.32B |
| 4 | RVMD | Revolution Medicines, Inc. | 44.85B | 2.72% | 200,205 | - |
| 5 | ONC | BeOne Medicines AG | 40.86B | 3.42% | 164,686 | 6.13B |
| 6 | RPRX | Royalty Pharma plc | 33.95B | 0.75% | 279,046 | 2.54B |
| 7 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.24B | -1.16% | 297,725 | 4.80B |
| 8 | INSM | Insmed Incorporated | 27.69B | 2.47% | 283,740 | 1.14B |
| 9 | ROIV | Roivant Sciences Ltd. | 26.04B | -0.41% | 1,243,849 | 7.53M |
| 10 | MRNA | Moderna, Inc. | 25.87B | 2.34% | 878,382 | 2.23B |
| 11 | INCY | Incyte Corporation | 24.78B | 1.76% | 135,523 | 5.82B |
| 12 | BNTX | BioNTech SE | 23.11B | -1.16% | 82,877 | 3.03B |
| 13 | GMAB | Genmab A/S | 18.75B | 2.47% | 775,174 | 4.13B |
| 14 | ASND | Ascendis Pharma A/S | 16.06B | -1.58% | 97,510 | 1.20B |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 15.99B | 0.55% | 58,376 | 4.60B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 15.31B | -1.93% | 528,161 | 713.07M |
| 17 | BMRN | BioMarin Pharmaceutical Inc. | 13.02B | -0.13% | 247,561 | 3.41B |
| 18 | EXEL | Exelixis, Inc. | 12.86B | 1.31% | 240,517 | 2.44B |
| 19 | CORT | Corcept Therapeutics Incorporated | 12.47B | 0.81% | 99,491 | 830.81M |
| 20 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.46B | 1.78% | 117,988 | 669.50M |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.88B | 1.27% | 40,628 | 1.28B |
| 22 | HALO | Halozyme Therapeutics, Inc. | 11.63B | 3.85% | 389,420 | 1.66B |
| 23 | TECH | Bio-Techne Corporation | 11.29B | 0.10% | 483,350 | 1.22B |
| 24 | AXSM | Axsome Therapeutics, Inc. | 11.21B | 0.15% | 70,473 | 776.57M |
| 25 | PRAX | Praxis Precision Medicines, Inc. | 10.75B | 4.96% | 58,153 | 7.46M |
| 26 | CYTK | Cytokinetics, Incorporated | 10.37B | 0.65% | 125,647 | 67.67M |
| 27 | ABVX | ABIVAX Société Anonyme | 10.25B | 2.56% | 205,507 | 5.67M |
| 28 | APGE | Apogee Therapeutics, Inc. | 10.15B | - | 216,453 | - |
| 29 | SMMT | Summit Therapeutics Inc. | 10.10B | -5.17% | 4,024,932 | - |
| 30 | PTGX | Protagonist Therapeutics, Inc. | 10.03B | -0.03% | 41,435 | 281.99M |
| 31 | KYMR | Kymera Therapeutics, Inc. | 10.00B | 2.45% | 93,427 | 105.00M |
| 32 | KRYS | Krystal Biotech, Inc. | 9.84B | 0.07% | 18,342 | 440.48M |
| 33 | IONS | Ionis Pharmaceuticals, Inc. | 9.63B | 1.19% | 317,721 | 874.09M |
| 34 | SYRE | Spyre Therapeutics, Inc. | 9.10B | -0.45% | 80,310 | - |
| 35 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.98B | - | 291,381 | 42.16M |
| 36 | PCVX | Vaxcyte, Inc. | 8.88B | 2.76% | 55,403 | - |
| 37 | IMVT | Immunovant, Inc. | 8.82B | 2.13% | 150,597 | - |
| 38 | IBRX | ImmunityBio, Inc. | 8.23B | 2.64% | 1,358,369 | 165.79M |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.99B | 0.46% | 49,660 | 239.92M |
| 40 | ORKA | Oruka Therapeutics, Inc. | 7.39B | 0.57% | 65,505 | - |
| 41 | TGTX | TG Therapeutics, Inc. | 7.03B | 1.74% | 107,222 | 799.54M |
| 42 | CGON | CG Oncology, Inc. | 6.77B | 1.83% | 87,964 | 6.23M |
| 43 | COGT | Cogent Biosciences, Inc. | 6.57B | -0.18% | 237,926 | - |
| 44 | MIRM | Mirum Pharmaceuticals, Inc. | 6.55B | 0.24% | 43,445 | 618.07M |
| 45 | BLTE | Belite Bio, Inc | 6.47B | 1.06% | 28,893 | - |
| 46 | DNTH | Dianthus Therapeutics, Inc. | 6.43B | -0.93% | 85,263 | 1.90M |
| 47 | ERAS | Erasca, Inc. | 6.43B | -0.05% | 305,610 | - |
| 48 | SRRK | Scholar Rock Holding Corporation | 6.35B | -0.76% | 80,714 | - |
| 49 | CAI | Caris Life Sciences, Inc. | 6.16B | 0.05% | 440,308 | 989.61M |
| 50 | PTCT | PTC Therapeutics, Inc. | 6.05B | 1.17% | 94,477 | 1.01B |
| 51 | XENE | Xenon Pharmaceuticals Inc. | 5.98B | -0.98% | 82,751 | 7.50M |
| 52 | DFTX | Definium Therapeutics, Inc. | 5.96B | 4.11% | 334,438 | - |
| 53 | TVTX | Travere Therapeutics, Inc. | 5.88B | 0.34% | 165,710 | 591.33M |
| 54 | LGND | Ligand Pharmaceuticals Incorporated | 5.86B | -0.19% | 20,329 | 290.54M |
| 55 | CRSP | CRISPR Therapeutics AG | 5.24B | 1.21% | 195,753 | 13.39M |
| 56 | ACAD | ACADIA Pharmaceuticals Inc. | 4.93B | 1.42% | 188,109 | 1.14B |
| 57 | DYN | Dyne Therapeutics, Inc. | 4.78B | -0.43% | 129,453 | - |
| 58 | PBLS | Parabilis Medicines, Inc. | 4.77B | 4.15% | 50,789 | 148.00K |
| 59 | EWTX | Edgewise Therapeutics, Inc. | 4.71B | -1.86% | 100,682 | - |
| 60 | MANE | Veradermics, Incorporated | 4.53B | -3.76% | 91,011 | - |
| 61 | CELC | Celcuity Inc. | 4.52B | 0.43% | 133,280 | - |
| 62 | RLAY | Relay Therapeutics, Inc. | 4.39B | 0.78% | 190,911 | 10.35M |
| 63 | TNGX | Tango Therapeutics, Inc. | 4.30B | -0.39% | 135,152 | 53.81M |
| 64 | ELVN | Enliven Therapeutics, Inc. | 4.29B | -0.56% | 49,084 | - |
| 65 | TLX | Telix Pharmaceuticals Limited | 3.96B | -0.51% | 17,629 | 803.79M |
| 66 | LEGN | Legend Biotech Corporation | 3.95B | 0.15% | 185,840 | 1.27B |
| 67 | DNLI | Denali Therapeutics Inc. | 3.90B | - | 129,307 | 3.60M |
| 68 | VKTX | Viking Therapeutics, Inc. | 3.87B | - | 370,956 | - |
| 69 | GPCR | Structure Therapeutics Inc. | 3.82B | -1.66% | 31,790 | - |
| 70 | RCUS | Arcus Biosciences, Inc. | 3.77B | 0.56% | 208,702 | 117.00M |
| 71 | ABCL | AbCellera Biologics Inc. | 3.53B | -4.22% | 2,149,821 | 66.17M |
| 72 | IDYA | IDEAYA Biosciences, Inc. | 3.50B | -0.03% | 39,172 | 234.13M |
| 73 | MBX | MBX Biosciences, Inc. | 3.34B | 1.21% | 101,468 | - |
| 74 | CLDX | Celldex Therapeutics, Inc. | 3.31B | 0.36% | 45,819 | 158.00K |
| 75 | ARQT | Arcutis Biotherapeutics, Inc. | 3.30B | 0.23% | 220,117 | 463.98M |
| 76 | QURE | uniQure N.V. | 3.29B | -2.50% | 107,203 | 18.67M |
| 77 | ALMS | Alumis Inc. | 3.28B | 0.24% | 78,442 | 7.40M |
| 78 | NAMS | NewAmsterdam Pharma Company N.V. | 3.19B | -1.15% | 120,400 | 7.12M |
| 79 | IMNM | Immunome, Inc. | 3.13B | 1.18% | 178,549 | 4.02M |
| 80 | IOVA | Iovance Biotherapeutics, Inc. | 3.13B | -1.15% | 3,302,868 | 324.97M |
| 81 | TARS | Tarsus Pharmaceuticals, Inc. | 3.06B | 0.81% | 25,978 | 606.33M |
| 82 | IRON | Disc Medicine, Inc. | 3.01B | -0.62% | 72,513 | - |
| 83 | ZLAB | Zai Lab Limited | 2.87B | -1.20% | 398,402 | 449.61M |
| 84 | NRIX | Nurix Therapeutics, Inc. | 2.80B | -0.22% | 106,285 | 36.77M |
| 85 | BEAM | Beam Therapeutics Inc. | 2.71B | 1.29% | 203,389 | 156.04M |
| 86 | ATAI | AtaiBeckley Inc. | 2.69B | -0.21% | 2,012,649 | 4.47M |
| 87 | KOD | Kodiak Sciences Inc. | 2.65B | 2.30% | 129,258 | - |
| 88 | VRDN | Viridian Therapeutics, Inc. | 2.63B | 5.25% | 302,449 | 71.13M |
| 89 | TRVI | Trevi Therapeutics, Inc. | 2.63B | 0.05% | 62,140 | - |
| 90 | SLS | SELLAS Life Sciences Group, Inc. | 2.63B | 1.72% | 1,124,107 | - |
| 91 | RARE | Ultragenyx Pharmaceutical Inc. | 2.58B | -0.76% | 123,896 | 717.00M |
| 92 | NKTR | Nektar Therapeutics | 2.52B | 1.25% | 216,676 | 54.59M |
| 93 | COAG | Hemab Therapeutics Holdings, Inc. | 2.50B | -2.62% | 27,810 | - |
| 94 | PHVS | Pharvaris N.V. | 2.48B | 0.37% | 105,373 | - |
| 95 | URGN | UroGen Pharma Ltd. | 2.37B | 0.48% | 58,109 | 188.73M |
| 96 | KLRA | Kailera Therapeutics, Inc. | 2.35B | 0.84% | 63,136 | - |
| 97 | OCUL | Ocular Therapeutix, Inc. | 2.34B | 6.18% | 3,614,794 | 52.06M |
| 98 | RAPP | Rapport Therapeutics, Inc. | 2.34B | 2.80% | 33,833 | 20.00M |
| 99 | PGEN | Precigen, Inc. | 2.30B | 5.41% | 901,018 | 85.72M |
| 100 | VERA | Vera Therapeutics, Inc. | 2.27B | -0.35% | 451,846 | - |
| 101 | MESO | Mesoblast Limited | 2.26B | 9.78% | 202,353 | 65.38M |
| 102 | VCEL | Vericel Corporation | 2.26B | -0.25% | 27,833 | 306.30M |
| 103 | MLYS | Mineralys Therapeutics, Inc. | 2.26B | -0.51% | 126,543 | - |
| 104 | PVLA | Palvella Therapeutics, Inc. | 2.25B | -0.08% | 33,411 | - |
| 105 | HRMY | Harmony Biosciences Holdings, Inc. | 2.21B | -0.31% | 67,526 | 959.90M |
| 106 | BHVN | Biohaven Ltd. | 2.21B | -0.14% | 218,198 | - |
| 107 | NUVB | Nuvation Bio Inc. | 2.19B | 0.48% | 727,554 | 169.90M |
| 108 | ADMA | ADMA Biologics, Inc. | 2.14B | 0.74% | 216,222 | 512.28M |
| 109 | SEPN | Septerna, Inc. | 2.11B | 1.62% | 78,040 | 98.88M |
| 110 | STOK | Stoke Therapeutics, Inc. | 2.05B | 1.66% | 35,386 | 27.59M |
| 111 | AUPH | Aurinia Pharmaceuticals Inc. | 2.05B | -0.39% | 133,932 | 311.51M |
| 112 | GHRS | GH Research PLC | 2.02B | -0.27% | 24,943 | - |
| 113 | AGIO | Agios Pharmaceuticals, Inc. | 2.00B | - | 70,002 | 98.34M |
| 114 | GENB | Generate Biomedicines, Inc. | 2.00B | -0.38% | 91,599 | 26.48M |
| 115 | TSHA | Taysha Gene Therapies, Inc. | 1.97B | 1.60% | 421,924 | 5.49M |
| 116 | ZBIO | Zenas BioPharma, Inc. | 1.96B | 2.00% | 57,746 | 1.00M |
| 117 | DMRA | Damora Therapeutics, Inc. | 1.94B | 1.45% | 110,424 | - |
| 118 | FBRX | Forte Biosciences, Inc. | 1.94B | 0.03% | 226,526 | - |
| 119 | SRPT | Sarepta Therapeutics, Inc. | 1.91B | -0.28% | 245,715 | 1.97B |
| 120 | NBTX | Nanobiotix S.A. | 1.90B | 4.33% | 126,243 | 38.27M |
| 121 | KARD | Kardigan, Inc. | 1.86B | -1.44% | 47,448 | - |
| 122 | LKFT | Lakefront Biotherapeutics NV | 1.82B | 1.42% | 60,383 | 1.13B |
| 123 | ZYME | Zymeworks Inc. | 1.79B | 0.28% | 41,574 | 37.13M |
| 124 | SNDX | Syndax Pharmaceuticals, Inc. | 1.78B | 0.71% | 98,034 | 252.25M |
| 125 | IMCR | Immunocore Holdings plc | 1.77B | 0.73% | 64,635 | 430.78M |
| 126 | BRVE | Braveheart Bio, Inc. | 1.77B | 1.89% | 127,657 | - |
| 127 | AVLN | Avalyn Pharma Inc. | 1.74B | -0.28% | 28,870 | - |
| 128 | ANAB | AnaptysBio, Inc. | 1.73B | -0.03% | 24,249 | 232.39M |
| 129 | XNCR | Xencor, Inc. | 1.72B | -0.79% | 152,129 | 104.97M |
| 130 | NTLA | Intellia Therapeutics, Inc. | 1.69B | 1.18% | 492,629 | 59.51M |
| 131 | RXRX | Recursion Pharmaceuticals, Inc. | 1.67B | -1.27% | 2,307,106 | 54.86M |
| 132 | FTRE | Fortrea Holdings Inc. | 1.67B | 0.75% | 121,312 | 2.68B |
| 133 | AAPG | Ascentage Pharma Group International | 1.65B | -3.82% | 1,150 | 82.08M |
| 134 | BCAX | Bicara Therapeutics Inc. | 1.62B | 1.09% | 47,729 | - |
| 135 | VIR | Vir Biotechnology, Inc. | 1.57B | 0.54% | 201,992 | 303.23M |
| 136 | TRAX | First Tracks Biotherapeutics, Inc. | 1.57B | -0.41% | 50,961 | - |
| 137 | JBIO | Jade Biosciences, Inc. | 1.56B | -0.57% | 141,161 | - |
| 138 | TYRA | Tyra Biosciences, Inc. | 1.55B | 2.91% | 193,152 | - |
| 139 | ABSI | Absci Corporation | 1.55B | -1.63% | 314,894 | 1.56M |
| 140 | SLBT | SL Science Holding Limited | 1.54B | 1.78% | 6,248 | 3.27M |
| 141 | INVA | Innoviva, Inc. | 1.52B | -0.64% | 42,898 | 440.00M |
| 142 | MAZE | Maze Therapeutics, Inc. | 1.52B | 0.59% | 24,800 | 20.00M |
| 143 | LBRX | LB Pharmaceuticals Inc | 1.52B | -1.56% | 18,121 | - |
| 144 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.48B | -0.18% | 158,717 | 208.78M |
| 145 | AVBP | ArriVent BioPharma, Inc. | 1.43B | -1.52% | 70,178 | - |
| 146 | MLTX | MoonLake Immunotherapeutics | 1.41B | 0.79% | 125,050 | - |
| 147 | ORIC | ORIC Pharmaceuticals, Inc. | 1.40B | -2.60% | 126,029 | - |
| 148 | SVRA | Savara Inc. | 1.36B | -0.56% | 244,658 | - |
| 149 | AKTS | Aktis Oncology, Inc. | 1.36B | -2.13% | 24,162 | 10.06M |
| 150 | VOR | Vor Biopharma Inc. | 1.34B | -1.74% | 83,203 | - |
| 151 | NVAX | Novavax, Inc. | 1.34B | 0.75% | 393,951 | 413.80M |
| 152 | REPL | Replimune Group, Inc. | 1.33B | -5.48% | 832,434 | - |
| 153 | GLUE | Monte Rosa Therapeutics, Inc. | 1.33B | 0.65% | 86,742 | 28.73M |
| 154 | CGEM | Cullinan Therapeutics, Inc. | 1.33B | 1.47% | 96,593 | - |
| 155 | SPTX | Seaport Therapeutics, Inc. | 1.32B | 1.78% | 15,817 | - |
| 156 | INBX | Inhibrx Biosciences, Inc. | 1.31B | 0.93% | 27,306 | 1.30M |
| 157 | DRTS | Alpha Tau Medical Ltd. | 1.31B | -0.35% | 96,863 | - |
| 158 | APMD | Apnimed, Inc. | 1.31B | 3.65% | 115,919 | 120.15M |
| 159 | MGTX | MeiraGTx Holdings plc | 1.31B | 0.89% | 130,274 | 397.50M |
| 160 | IMTX | Immatics N.V. | 1.30B | 0.42% | 102,756 | 43.00M |
| 161 | CRVS | Corvus Pharmaceuticals, Inc. | 1.28B | 1.95% | 100,365 | - |
| 162 | ANRO | Alto Neuroscience, Inc. | 1.27B | 0.50% | 68,965 | - |
| 163 | MNKD | MannKind Corporation | 1.25B | 1.30% | 442,964 | 393.63M |
| 164 | OMER | Omeros Corporation | 1.24B | -0.17% | 701,000 | 38.42M |
| 165 | LTGO | Latigo Biotherapeutics, Inc. | 1.22B | -1.36% | 32,244 | - |
| 166 | SANA | Sana Biotechnology, Inc. | 1.08B | 1.69% | 363,114 | - |
| 167 | AVTX | Avalo Therapeutics, Inc. | 1.07B | 1.63% | 121,511 | 59.00K |
| 168 | IVA | Inventiva S.A. | 1.06B | 2.07% | 105,275 | 7.94M |
| 169 | WVE | Wave Life Sciences Ltd. | 1.03B | -3.05% | 459,617 | 65.37M |
| 170 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.03B | -0.65% | 295,178 | 41.47M |
| 171 | ODTX | Odyssey Therapeutics, Inc. | 1.01B | 1.78% | 21,004 | 99.00K |
| 172 | ARDX | Ardelyx, Inc. | 1.00B | -0.99% | 556,543 | 450.89M |
| 173 | KURA | Kura Oncology, Inc. | 987.46M | 2.21% | 241,324 | 77.23M |
| 174 | JANX | Janux Therapeutics, Inc. | 986.14M | 0.06% | 58,265 | 24.00M |
| 175 | ANNX | Annexon, Inc. | 982.97M | -1.98% | 480,326 | - |
| 176 | SLDB | Solid Biosciences Inc. | 963.95M | -2.28% | 97,022 | - |
| 177 | CLYM | Climb Bio, Inc. | 958.61M | 2.20% | 292,236 | - |
| 178 | GERN | Geron Corporation | 941.22M | -0.34% | 1,010,974 | 204.56M |
| 179 | OLMA | Olema Pharmaceuticals, Inc. | 937.54M | 0.80% | 130,303 | - |
| 180 | ABUS | Arbutus Biopharma Corporation | 934.83M | 1.18% | 399,187 | 181.72M |
| 181 | DSGN | Design Therapeutics, Inc. | 928.09M | - | 83,739 | - |
| 182 | FTH | Faeth Therapeutics, Inc. | 905.19M | 8.32% | 134,310 | - |
| 183 | CADL | Candel Therapeutics, Inc. | 892.96M | -0.43% | 355,309 | - |
| 184 | TBPH | Theravance Biopharma, Inc. | 880.80M | -0.03% | 16,446 | 104.31M |
| 185 | ATTO | Attovia Therapeutics, Inc. | 872.20M | 2.06% | 78,524 | 1.35M |
| 186 | SGP | SpyGlass Pharma, Inc. | 862.12M | -1.62% | 11,891 | - |
| 187 | ACRS | Aclaris Therapeutics, Inc. | 858.17M | 0.87% | 91,989 | 8.22M |
| 188 | SLN | Silence Therapeutics plc | 826.07M | - | 88,369 | 615.00K |
| 189 | PHAR | Pharming Group N.V. | 814.40M | 1.66% | 6,384 | 366.48M |
| 190 | DBVT | DBV Technologies S.A. | 810.62M | 5.21% | 44,334 | 5.04M |
| 191 | IMMX | Immix Biopharma, Inc. | 809.11M | 3.10% | 253,036 | - |
| 192 | OBX | Obsidian Therapeutics, Inc. | 805.44M | 4.61% | 10,493 | - |
| 193 | OCS | Oculis Holding AG | 801.28M | 0.31% | 26,429 | 1.45M |
| 194 | RIGL | Rigel Pharmaceuticals, Inc. | 793.89M | -0.19% | 44,754 | 276.79M |
| 195 | AURA | Aura Biosciences, Inc. | 793.34M | -0.52% | 1,298,320 | - |
| 196 | MNPR | Monopar Therapeutics Inc. | 778.11M | 2.55% | 46,409 | - |
| 197 | FDMT | 4D Molecular Therapeutics, Inc. | 774.52M | 15.01% | 412,071 | 92.01M |
| 198 | DRUG | Bright Minds Biosciences Inc. | 762.98M | -0.63% | 47,192 | - |
| 199 | CBIO | Crescent Biopharma, Inc. | 759.72M | 3.56% | 13,753 | 11.88M |
| 200 | ACHV | Achieve Life Sciences, Inc. | 755.30M | -3.29% | 255,539 | - |
| 201 | CTMX | CytomX Therapeutics, Inc. | 745.22M | 1.79% | 275,075 | 18.30M |
| 202 | STTK | Shattuck Labs, Inc. | 738.67M | -0.81% | 72,589 | 1.00M |
| 203 | PHAT | Phathom Pharmaceuticals, Inc. | 738.30M | -2.97% | 99,353 | 239.66M |
| 204 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 734.40M | 1.10% | 72,341 | - |
| 205 | NGNE | Neurogene Inc. | 731.42M | 1.13% | 10,566 | 925.00K |
| 206 | HELP | Cybin Inc. | 725.83M | -2.34% | 289,583 | - |
| 207 | RGNX | REGENXBIO Inc. | 720.86M | 1.44% | 169,848 | 174.48M |
| 208 | ALLO | Allogene Therapeutics, Inc. | 720.35M | 1.71% | 569,662 | 4.64M |
| 209 | GYRE | Gyre Therapeutics, Inc. | 708.31M | - | 7,626 | 109.82M |
| 210 | SGMT | Sagimet Biosciences Inc. | 689.96M | 5.21% | 462,262 | - |
| 211 | ZVRA | Zevra Therapeutics, Inc. | 681.13M | 1.33% | 109,936 | 136.07M |
| 212 | TECX | Tectonic Therapeutic, Inc. | 677.29M | -0.76% | 13,904 | - |
| 213 | AGMB | AgomAb Therapeutics NV | 667.80M | 2.57% | 20,715 | - |
| 214 | VALN | Valneva SE | 658.72M | 1.96% | 68,574 | 163.30M |
| 215 | ASMB | Assembly Biosciences, Inc. | 651.95M | -2.82% | 56,569 | 74.85M |
| 216 | CRMD | CorMedix Inc. | 629.79M | 7.16% | 727,980 | 462.25M |
| 217 | MDXG | MiMedx Group, Inc. | 619.48M | -0.47% | 118,910 | 355.17M |
| 218 | NVCT | Nuvectis Pharma, Inc. | 618.72M | 0.16% | 23,494 | - |
| 219 | VSTM | Verastem, Inc. | 616.74M | 3.50% | 397,074 | 87.53M |
| 220 | AUTL | Autolus Therapeutics plc | 608.18M | 6.28% | 733,323 | 117.39M |
| 221 | ARVN | Arvinas, Inc. | 600.90M | 2.45% | 88,816 | 316.70M |
| 222 | PRLD | Prelude Therapeutics Incorporated | 599.43M | 4.86% | 44,824 | 22.42M |
| 223 | SPRY | ARS Pharmaceuticals, Inc. | 592.71M | 5.49% | 479,535 | 116.93M |
| 224 | EIKN | Eikon Therapeutics, Inc. | 589.32M | -1.54% | 122,055 | - |
| 225 | OABI | OmniAb, Inc. | 584.47M | 18.93% | 6,871,530 | 38.46M |
| 226 | ALT | Altimmune, Inc. | 582.58M | 1.87% | 1,523,574 | 31.00K |
| 227 | ARTV | Artiva Biotherapeutics, Inc. | 567.13M | 1.31% | 27,892 | 251.00K |
| 228 | OVID | Ovid Therapeutics Inc. | 566.36M | 2.47% | 330,563 | 1.58M |
| 229 | CTNM | Contineum Therapeutics, Inc. | 559.61M | 4.83% | 1,529,864 | - |
| 230 | PRME | Prime Medicine, Inc. | 558.62M | 1.62% | 302,996 | 4.07M |
| 231 | ZURA | Zura Bio Limited | 540.48M | 1.26% | 51,667 | - |
| 232 | MPLT | MapLight Therapeutics, Inc. | 538.45M | -1.19% | 25,019 | - |
| 233 | EVMN | Evommune, Inc. | 529.14M | -0.48% | 39,351 | 10.00M |
| 234 | ANL | Adlai Nortye Ltd. | 517.35M | -2.39% | 22,473 | 19.54M |
| 235 | KYTX | Kyverna Therapeutics, Inc. | 517.01M | 2.33% | 108,815 | - |
| 236 | CCCC | C4 Therapeutics, Inc. | 513.01M | -1.65% | 437,247 | 35.04M |
| 237 | RLMD | Relmada Therapeutics, Inc. | 512.55M | 0.10% | 133,484 | - |
| 238 | ENTX | Entera Bio Ltd. | 495.19M | -1.04% | 24,498 | 42.00K |
| 239 | BLSM | BlossomHill Therapeutics, Inc. | 494.59M | -0.25% | 18,110 | - |
| 240 | RZLT | Rezolute, Inc. | 487.86M | 1.52% | 65,177 | - |
| 241 | CABA | Cabaletta Bio, Inc. | 478.12M | 2.55% | 711,919 | - |
| 242 | QTTB | Q32 Bio Inc. | 469.46M | 4.09% | 47,640 | 53.74M |
| 243 | PBYI | Puma Biotechnology, Inc. | 461.48M | 1.25% | 45,878 | 231.24M |
| 244 | DNA | Ginkgo Bioworks Holdings, Inc. | 459.93M | 0.59% | 159,077 | 132.42M |
| 245 | OCGN | Ocugen, Inc. | 457.80M | - | 727,145 | 4.58M |
| 246 | PRTA | Prothena Corporation plc | 456.90M | 0.45% | 47,526 | 54.53M |
| 247 | LRMR | Larimar Therapeutics, Inc. | 451.46M | -0.80% | 127,207 | - |
| 248 | EPRX | Eupraxia Pharmaceuticals Inc. | 442.16M | 0.89% | 14,397 | - |
| 249 | BNTC | Benitec Biopharma Inc. | 435.61M | 0.96% | 6,607 | - |
| 250 | IKT | Inhibikase Therapeutics, Inc. | 435.16M | -0.83% | 66,997 | 1.00 |
| 251 | EDIT | Editas Medicine, Inc. | 434.63M | 0.35% | 296,288 | 47.01M |
| 252 | XFOR | X4 Pharmaceuticals, Inc. | 423.85M | 1.30% | 152,053 | 15.85M |
| 253 | FENC | Fennec Pharmaceuticals Inc. | 416.25M | 1.28% | 31,735 | 59.22M |
| 254 | CMPX | Compass Therapeutics, Inc. | 415.10M | 2.44% | 323,812 | 850.00K |
| 255 | AVIR | Atea Pharmaceuticals, Inc. | 414.66M | 0.98% | 54,971 | - |
| 256 | CAPR | Capricor Therapeutics, Inc. | 409.30M | 5.86% | 6,493,609 | 11.13M |
| 257 | PROK | ProKidney Corp. | 408.14M | 1.50% | 146,675 | 818.00K |
| 258 | SCTX | Scribe Therapeutics Inc. | 405.02M | 3.57% | 13,914 | 36.28M |
| 259 | LXEO | Lexeo Therapeutics, Inc. | 402.01M | 1.24% | 94,151 | - |
| 260 | FHTX | Foghorn Therapeutics Inc. | 391.94M | 5.43% | 22,643 | 36.74M |
| 261 | PALI | Palisade Bio, Inc. | 385.14M | 3.27% | 384,776 | 500.00K |
| 262 | ENTA | Enanta Pharmaceuticals, Inc. | 382.42M | -0.23% | 25,164 | 65.26M |
| 263 | UPB | Upstream Bio, Inc. | 382.30M | -1.27% | 158,727 | 3.16M |
| 264 | EYPT | EyePoint, Inc. | 374.16M | -70.58% | 19,703,203 | 2.79M |
| 265 | RCKT | Rocket Pharmaceuticals, Inc. | 372.14M | -2.31% | 152,064 | - |
| 266 | VTVT | vTv Therapeutics Inc. | 370.26M | -1.06% | 2,262 | 36.84M |
| 267 | DMAC | DiaMedica Therapeutics Inc. | 361.30M | 0.30% | 35,653 | - |
| 268 | GALT | Galectin Therapeutics Inc. | 353.98M | 2.03% | 39,645 | - |
| 269 | IPSC | Century Therapeutics, Inc. | 351.29M | 1.04% | 59,858 | 109.16M |
| 270 | CUVL | Clinuvel Pharmaceuticals Limited | 349.99M | -5.07% | 480 | 64.24M |
| 271 | SABS | SAB Biotherapeutics, Inc. | 347.57M | 3.24% | 74,293 | 114.70K |
| 272 | STRO | Sutro Biopharma, Inc. | 345.05M | 1.61% | 26,443 | 45.70M |
| 273 | LYEL | Lyell Immunopharma, Inc. | 336.70M | -1.51% | 21,664 | 27.00K |
| 274 | ABEO | Abeona Therapeutics Inc. | 332.81M | -2.76% | 657,760 | 25.52M |
| 275 | VCRE | Vicore Pharma Holding AB (publ) | 331.56M | -5.10% | 2,953 | 370.61K |
| 276 | IMRX | Immuneering Corporation | 331.25M | 1.19% | 52,699 | - |
| 277 | AGEN | Agenus Inc. | 320.55M | -2.73% | 214,096 | 132.69M |
| 278 | VNDA | Vanda Pharmaceuticals Inc. | 318.94M | 1.05% | 133,967 | 215.72M |
| 279 | CAMP | Camp4 Therapeutics Corporation | 312.51M | -8.46% | 98,635 | 4.22M |
| 280 | IFRX | InflaRx N.V. | 306.53M | 1.96% | 109,705 | -11.54K |
| 281 | IRD | Opus Genetics, Inc. | 306.16M | 1.94% | 87,605 | 9.86M |
| 282 | SION | Sionna Therapeutics, Inc. | 306.09M | 4.80% | 582,044 | - |
| 283 | FATE | Fate Therapeutics, Inc. | 300.72M | 0.39% | 444,404 | 6.49M |
| 284 | ELDN | Eledon Pharmaceuticals, Inc. | 299.34M | 3.95% | 203,823 | - |
| 285 | AVXL | Anavex Life Sciences Corp. | 296.55M | -0.62% | 115,977 | - |
| 286 | FULC | Fulcrum Therapeutics, Inc. | 291.07M | 2.01% | 1,731,817 | 80.00M |
| 287 | SRZN | Surrozen, Inc. | 289.26M | 2.71% | 50,026 | 11.51M |
| 288 | TTRX | Turn Therapeutics Inc. | 287.90M | 0.99% | 22,004 | - |
| 289 | NMRA | Neumora Therapeutics, Inc. | 279.96M | -6.88% | 172,543 | - |
| 290 | PRQR | ProQR Therapeutics N.V. | 279.42M | 3.13% | 273,865 | 21.05M |
| 291 | BCYC | Bicycle Therapeutics plc | 277.17M | 1.54% | 85,895 | 61.21M |
| 292 | OBIO | Orchestra BioMed Holdings, Inc. | 277.08M | 4.54% | 67,137 | 31.98M |
| 293 | LCTX | Lineage Cell Therapeutics, Inc. | 275.67M | 1.87% | 123,380 | 13.08M |
| 294 | SLGL | Sol-Gel Technologies Ltd. | 274.20M | -0.96% | 21,929 | 18.47M |
| 295 | RNAC | Cartesian Therapeutics, Inc. | 273.51M | 2.26% | 34,925 | 1.48M |
| 296 | ALXO | ALX Oncology Holdings Inc. | 273.10M | 0.77% | 82,760 | - |
| 297 | TRDA | Entrada Therapeutics, Inc. | 266.10M | -1.07% | 24,602 | 4.69M |
| 298 | WHWK | Whitehawk Therapeutics, Inc. | 264.52M | 4.04% | 48,141 | 7.15M |
| 299 | MGNX | MacroGenics, Inc. | 264.36M | -1.66% | 114,806 | 175.14M |
| 300 | CNXU | Conexeu Sciences Inc. | 259.29M | 8.88% | 131,728 | - |
| 301 | ZNTL | Zentalis Pharmaceuticals, Inc. | 256.59M | 0.56% | 230,308 | 26.87M |
| 302 | GLSI | Greenwich LifeSciences, Inc. | 253.93M | 2.98% | 19,876 | - |
| 303 | ACIU | AC Immune SA | 250.06M | 1.00% | 22,832 | 21.67M |
| 304 | PYXS | Pyxis Oncology, Inc. | 247.72M | -1.33% | 160,928 | 11.04M |
| 305 | ADAG | Adagene Inc. | 247.09M | -0.54% | 196,126 | 9.29M |
| 306 | NAGE | Niagen Bioscience, Inc. | 235.50M | -1.66% | 112,394 | 129.08M |
| 307 | TARA | Protara Therapeutics, Inc. | 235.20M | 0.25% | 46,034 | - |
| 308 | NBP | NovaBridge Biosciences | 228.98M | 1.02% | 129,312 | - |
| 309 | ARCT | Arcturus Therapeutics Holdings Inc. | 228.81M | -2.19% | 114,159 | 29.37M |
| 310 | CLLS | Cellectis S.A. | 228.78M | 1.97% | 13,622 | 63.82M |
| 311 | ANTX | AN2 Therapeutics, Inc. | 226.79M | 0.33% | 64,126 | - |
| 312 | CGEN | Compugen Ltd. | 226.39M | -0.83% | 80,674 | 74.00M |
| 313 | RNA | Atrium Therapeutics, Inc. | 223.91M | 1.95% | 112,639 | 35.84M |
| 314 | ALEC | Alector, Inc. | 222.20M | 1.53% | 93,831 | 13.86M |
| 315 | IMUX | Immunic, Inc. | 218.45M | -0.31% | 56,313 | - |
| 316 | VOGX | Vogenx, Inc. | 217.11M | 5.55% | 5,510 | - |
| 317 | TNXP | Tonix Pharmaceuticals Holding Corp. | 214.73M | -1.49% | 114,374 | 29.10M |
| 318 | YDES | YD Bio Limited | 213.07M | 1.68% | 19,996 | 510.36K |
| 319 | NERV | Minerva Neurosciences, Inc. | 212.95M | -2.62% | 17,914 | - |
| 320 | IVVD | Invivyd, Inc. | 212.76M | 0.12% | 394,812 | 58.37M |
| 321 | DTIL | Precision BioSciences, Inc. | 205.91M | 0.40% | 61,602 | 45.06M |
| 322 | PEPG | PepGen Inc. | 203.62M | -1.67% | 67,929 | - |
| 323 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 203.08M | 4.06% | 158,857 | - |
| 324 | IPHA | Innate Pharma S.A. | 202.05M | -0.46% | 27,711 | 10.57M |
| 325 | KROS | Keros Therapeutics, Inc. | 202.04M | 0.89% | 37,205 | 15.01M |
| 326 | KRRO | Korro Bio, Inc. | 200.86M | 2.71% | 8,539 | 2.38M |
| 327 | MSLE | Satellos Bioscience Inc. | 200.85M | - | 2,967 | - |
| 328 | VYGR | Voyager Therapeutics, Inc. | 197.49M | -1.99% | 51,045 | 34.46M |
| 329 | ABOS | Acumen Pharmaceuticals, Inc. | 197.43M | 2.25% | 81,210 | - |
| 330 | ORMP | Oramed Pharmaceuticals Inc. | 188.44M | 1.12% | 36,341 | 2.00M |
| 331 | CHRS | Coherus Oncology, Inc. | 185.40M | - | 207,577 | 50.94M |
| 332 | PLX | Protalix BioTherapeutics, Inc. | 184.51M | 3.15% | 378,036 | 80.62M |
| 333 | ACOG | Alpha Cognition Inc. | 183.45M | -4.69% | 36,085 | 15.26M |
| 334 | NGEN | NervGen Pharma Corp. | 175.58M | -4.90% | 151,722 | - |
| 335 | MDWD | MediWound Ltd. | 175.00M | -0.04% | 7,395 | 11.86M |
| 336 | CDXS | Codexis, Inc. | 174.11M | 1.92% | 405,010 | 77.68M |
| 337 | NKTX | Nkarta, Inc. | 171.18M | 2.58% | 96,262 | - |
| 338 | CRBU | Caribou Biosciences, Inc. | 169.39M | - | 292,808 | 10.04M |
| 339 | ARMP | Armata Pharmaceuticals, Inc. | 166.95M | -1.54% | 5,105 | 5.54M |
| 340 | OKUR | OnKure Therapeutics, Inc. | 164.42M | 1.75% | 8,344 | - |
| 341 | HUMA | Humacyte, Inc. | 163.51M | -2.68% | 989,287 | 2.12M |
| 342 | CNTB | Connect Biopharma Holdings Limited | 159.33M | -0.78% | 130,547 | 2.95M |
| 343 | KZIA | Kazia Therapeutics Limited | 157.01M | 1.63% | 21,275 | 1.27M |
| 344 | CNTN | Canton Strategic Holdings, Inc. | 156.97M | -2.48% | 61,410 | 1.50M |
| 345 | MOLN | Molecular Partners AG | 155.76M | 2.14% | 1,536 | 856.30K |
| 346 | TNYA | Tenaya Therapeutics, Inc. | 154.61M | -5.30% | 1,776,827 | 1.34M |
| 347 | MIST | Milestone Pharmaceuticals Inc. | 154.30M | -0.45% | 275,464 | 2.34M |
| 348 | UNCY | Unicycive Therapeutics, Inc. | 152.09M | -0.91% | 73,144 | - |
| 349 | AARD | Aardvark Therapeutics, Inc. | 151.66M | 5.96% | 57,210 | - |
| 350 | HURA | TuHURA Biosciences, Inc. | 150.29M | -4.45% | 106,516 | - |
| 351 | LENZ | LENZ Therapeutics, Inc. | 149.56M | 0.63% | 58,687 | 21.48M |
| 352 | SPRB | Spruce Biosciences, Inc. | 149.10M | -1.44% | 7,194 | 697.00K |
| 353 | EQ | Equillium, Inc. | 147.95M | -0.85% | 37,850 | 4.39M |
| 354 | OTLK | Outlook Therapeutics, Inc. | 144.92M | 2.46% | 14,676,929 | -1.16M |
| 355 | MENS | Jyong Biotech Ltd. | 144.01M | -3.96% | 23,072 | - |
| 356 | TLSA | Tiziana Life Sciences Ltd | 143.53M | -2.20% | 86,508 | - |
| 357 | NRXP | NRx Pharmaceuticals, Inc. | 139.14M | 1.53% | 276,304 | 3.39M |
| 358 | INDP | Indaptus Therapeutics, Inc. | 135.89M | 12.15% | 129,385 | - |
| 359 | CBUS | Cibus, Inc. | 132.82M | -1.69% | 30,757 | 4.35M |
| 360 | PMN | ProMIS Neurosciences, Inc. | 131.15M | -1.58% | 13,588 | - |
| 361 | CUE | Cue Biopharma, Inc. | 131.05M | -8.77% | 64,243 | 37.66M |
| 362 | PLYX | Polaryx Therapeutics, Inc. | 125.78M | -2.95% | 12,514 | - |
| 363 | INO | Inovio Pharmaceuticals, Inc. | 120.61M | 0.92% | 2,145,235 | 65.34K |
| 364 | BDTX | Black Diamond Therapeutics, Inc. | 118.93M | 2.48% | 73,494 | 70.00M |
| 365 | YARW | Yarrow Bioscience, Inc. | 118.13M | -0.71% | 5,083 | - |
| 366 | VANI | Vivani Medical, Inc. | 117.71M | -2.50% | 32,223 | - |
| 367 | GNLX | Genelux Corporation | 117.68M | -3.28% | 39,304 | 8.00K |
| 368 | ENGN | enGene Therapeutics Inc. | 114.55M | 0.59% | 166,980 | - |
| 369 | NAUT | Nautilus Biotechnology, Inc. | 114.53M | 0.90% | 149,244 | 190.00K |
| 370 | ANIX | Anixa Biosciences, Inc. | 113.64M | 5.03% | 93,720 | - |
| 371 | SEER | Seer, Inc. | 113.24M | -1.68% | 71,910 | 14.22M |
| 372 | COYA | Coya Therapeutics, Inc. | 110.01M | -2.09% | 18,150 | 8.02M |
| 373 | GUTS | Fractyl Health, Inc. | 109.77M | 1.41% | 164,264 | 3.00K |
| 374 | RANI | Rani Therapeutics Holdings, Inc. | 106.37M | -2.01% | 137,495 | 4.88M |
| 375 | TENX | Tenax Therapeutics, Inc. | 105.97M | 2.78% | 2,811,701 | - |
| 376 | NTHI | NeOnc Technologies Holdings, Inc. | 103.73M | -5.21% | 56,771 | 39.99K |
| 377 | BMEA | Biomea Fusion, Inc. | 100.03M | 4.55% | 283,408 | - |
| 378 | ONCY | Oncolytics Biotech Inc. | 98.62M | -0.92% | 195,834 | - |
| 379 | PYPD | PolyPid Ltd. | 98.11M | 1.90% | 20,966 | - |
| 380 | KLRS | Kalaris Therapeutics, Inc. | 98.08M | 0.98% | 4,053 | - |
| 381 | CGTX | Cognition Therapeutics, Inc. | 97.47M | 1.49% | 93,172 | - |
| 382 | PTHS | Pelthos Therapeutics Inc. | 96.45M | 0.91% | 3,692 | 43.30M |
| 383 | ACET | Adicet Bio, Inc. | 94.40M | 4.65% | 36,607 | - |
| 384 | ALDX | Aldeyra Therapeutics, Inc. | 94.11M | - | 192,837 | - |
| 385 | FBIO | Fortress Biotech, Inc. | 92.72M | -5.12% | 220,046 | 68.47M |
| 386 | GANX | Gain Therapeutics, Inc. | 91.65M | -0.94% | 71,340 | - |
| 387 | RLYB | Rallybio Corporation | 89.16M | -1.18% | 3,474 | 646.00K |
| 388 | ICCC | ImmuCell Corporation | 89.07M | -2.04% | 31,295 | 30.68M |
| 389 | ACRV | Acrivon Therapeutics, Inc. | 88.17M | 5.64% | 319,651 | - |
| 390 | VRCA | Verrica Pharmaceuticals Inc. | 85.72M | 0.40% | 119,440 | 30.32M |
| 391 | MAIA | MAIA Biotechnology, Inc. | 83.33M | -2.14% | 59,956 | - |
| 392 | ATHE | Alterity Therapeutics Limited | 81.72M | -5.01% | 25,291 | 4.43M |
| 393 | ELTX | Elicio Therapeutics, Inc. | 80.55M | -0.81% | 35,901 | - |
| 394 | NRXS | NeurAxis, Inc. | 80.37M | 1.59% | 6,360 | 5.32M |
| 395 | OKYO | OKYO Pharma Limited | 79.77M | - | 14,398 | - |
| 396 | ATRA | Atara Biotherapeutics, Inc. | 78.80M | -2.97% | 19,077 | 6.19M |
| 397 | ANVS | Annovis Bio, Inc. | 77.40M | -1.66% | 141,287 | - |
| 398 | TELO | Telomir Pharmaceuticals, Inc. | 76.00M | 1.38% | 6,310 | - |
| 399 | LONA | LeonaBio, Inc. | 75.34M | 0.69% | 15,446 | - |
| 400 | ELOX | Eloxx Pharmaceuticals, Inc. | 73.20M | -3.33% | 4,829 | - |
| 401 | IBIO | iBio, Inc. | 72.03M | 1.40% | 169,548 | 300.00K |
| 402 | CRDF | Cardiff Oncology, Inc. | 72.02M | -3.86% | 172,668 | 508.00K |
| 403 | GOSS | Gossamer Bio, Inc. | 71.71M | -4.86% | 5,931,581 | 53.29M |
| 404 | XBIT | XBiotech Inc. | 71.64M | 2.17% | 2,557 | - |
| 405 | DWTX | Dogwood Therapeutics, Inc. | 71.63M | -0.93% | 10,874 | - |
| 406 | SPRO | Spero Therapeutics, Inc. | 71.05M | -0.81% | 42,666 | 47.00M |
| 407 | CSBR | Champions Oncology, Inc. | 70.23M | -0.20% | 394 | 59.43M |
| 408 | CING | Cingulate Inc. | 70.04M | 2.16% | 23,496 | - |
| 409 | RNTX | Rein Therapeutics Inc. | 68.87M | -0.11% | 60,126 | - |
| 410 | PLRX | Pliant Therapeutics, Inc. | 68.42M | 3.27% | 218,666 | - |
| 411 | PMVP | PMV Pharmaceuticals, Inc. | 67.20M | - | 100,086 | - |
| 412 | IMA | ImageneBio, Inc. | 67.09M | 1.20% | 1,209 | 800.00K |
| 413 | HYFT | MindWalk Holdings Corp. | 66.25M | - | 14,872 | 11.43M |
| 414 | HRTX | Heron Therapeutics, Inc. | 65.50M | 2.47% | 254,704 | 151.18M |
| 415 | BOLD | Boundless Bio, Inc. | 64.60M | 0.35% | 23,344 | - |
| 416 | OSTX | OS Therapies Incorporated | 64.58M | -10.49% | 491,227 | - |
| 417 | MNOV | MediciNova, Inc. | 64.23M | -0.38% | 33,250 | 920.48K |
| 418 | XLO | Xilio Therapeutics, Inc. | 61.33M | 1.64% | 2,949 | 64.09M |
| 419 | RNXT | RenovoRx, Inc. | 59.98M | -5.00% | 345,481 | 1.98M |
| 420 | INMB | INmune Bio Inc. | 58.84M | -2.30% | 72,920 | 50.00K |
| 421 | EDSA | Edesa Biotech, Inc. | 57.22M | 11.03% | 47,016 | - |
| 422 | BSEM | BioStem Technologies, Inc. | 56.55M | -0.62% | 40,879 | 91.15M |
| 423 | INKT | MiNK Therapeutics, Inc. | 56.02M | -0.22% | 1,024 | - |
| 424 | APLM | Apollomics, Inc. | 54.90M | 6.84% | 23,575 | 8.84M |
| 425 | EXOZ | eXoZymes, Inc. | 54.66M | 3.09% | 981 | -700.00 |
| 426 | IMMP | Immutep Limited | 54.33M | 1.76% | 21,937 | 5.28M |
| 427 | TCRX | TScan Therapeutics, Inc. | 52.16M | -1.18% | 88,400 | 7.11M |
| 428 | ATYR | aTyr Pharma, Inc. | 51.70M | -5.71% | 235,300 | 190.00K |
| 429 | TIL | Instil Bio, Inc. | 50.19M | 0.27% | 1,857 | - |
| 430 | ALPS | Alps Group Inc | 49.95M | -6.19% | 24,471 | 3.74M |
| 431 | IBO | Impact BioMedical Inc. | 49.53M | 0.01% | 3,180 | 35.00K |
| 432 | MREO | Mereo BioPharma Group plc | 47.91M | -5.93% | 747,969 | 500.00K |
| 433 | CNTX | Context Therapeutics Inc. | 47.63M | -0.87% | 154,385 | - |
| 434 | GRCE | Grace Therapeutics, Inc. | 46.70M | 2.78% | 36,065 | - |
| 435 | MGX | Metagenomi Therapeutics, Inc. | 46.09M | -0.81% | 19,009 | 13.56M |
| 436 | VERU | Veru Inc. | 45.87M | -1.47% | 31,820 | 16.89M |
| 437 | VRXA | Veraxa Biotech AG | 45.77M | -2.94% | 15,045 | - |
| 438 | MCRB | Seres Therapeutics, Inc. | 44.93M | -0.44% | 12,434 | 1.88M |
| 439 | KPTI | Karyopharm Therapeutics Inc. | 44.46M | -2.97% | 238,499 | 146.62M |
| 440 | FLNA | Filana Therapeutics, Inc. | 43.70M | -0.95% | 57,214 | - |
| 441 | HYPD | Hyperion DeFi, Inc. | 43.20M | 4.78% | 102,561 | 1.40M |
| 442 | ALGS | Aligos Therapeutics, Inc. | 41.46M | -3.63% | 14,082 | 31.52M |
| 443 | SER | Serina Therapeutics, Inc. | 41.02M | -2.32% | 16,243 | 130.00K |
| 444 | CRVO | CervoMed Inc. | 39.91M | -3.30% | 92,787 | 331.30K |
| 445 | NTRB | Nutriband Inc. | 39.83M | -0.72% | 924 | 1.80M |
| 446 | NXTC | NextCure, Inc. | 36.01M | -4.18% | 50,043 | - |
| 447 | ATNM | Actinium Pharmaceuticals, Inc. | 34.90M | 6.73% | 174,849 | 35.09M |
| 448 | RADX | Radiopharm Theranostics Limited | 33.82M | 1.95% | 2,208 | 10.86M |
| 449 | QNCX | Quince Therapeutics, Inc. | 33.58M | 0.88% | 4,888 | - |
| 450 | ESLA | Estrella Immunopharma, Inc. | 32.28M | 3.71% | 878 | - |
| 451 | BYSI | BeyondSpring Inc. | 32.05M | -7.10% | 117,748 | 1.88M |
| 452 | LTRN | Lantern Pharma Inc. | 31.83M | -6.04% | 13,099 | - |
| 453 | NNVC | NanoViricides, Inc. | 30.98M | -1.45% | 84,436 | - |
| 454 | GNTA | Genenta Science S.p.A. | 30.69M | 0.08% | 13,403 | - |
| 455 | LITS | Lite Strategy, Inc. | 30.58M | 1.36% | 31,092 | - |
| 456 | BCTX | BriaCell Therapeutics Corp. | 29.65M | -0.24% | 20,397 | - |
| 457 | GRDX | GridAI Technologies Corp. | 29.00M | -1.80% | 7,530 | - |
| 458 | IGC | IGC Pharma, Inc. | 28.78M | -6.51% | 217,617 | 1.11M |
| 459 | DYAI | Dyadic International, Inc. | 28.42M | 0.63% | 42,148 | 3.80M |
| 460 | KYNB | Kyntra Bio, Inc. | 28.22M | -1.13% | 16,191 | 4.62M |
| 461 | TVGN | Tevogen Inc. | 27.72M | -4.37% | 2,210 | - |
| 462 | ENLV | Enlivex Ltd. | 27.63M | - | 69,950 | - |
| 463 | EVAX | Evaxion A/S | 27.52M | -1.20% | 9,016 | 7.53M |
| 464 | CVM | CEL-SCI Corporation | 26.04M | -3.25% | 43,724 | - |
| 465 | ATOS | Atossa Therapeutics, Inc. | 25.95M | - | 41,224 | - |
| 466 | JSPR | Jasper Therapeutics, Inc. | 24.91M | -5.06% | 247,981 | - |
| 467 | BRNS | Barinthus Biotherapeutics plc | 24.88M | 3.05% | 499 | 14.97M |
| 468 | LGVN | Longeveron Inc. | 24.83M | 6.22% | 185,604 | 1.19M |
| 469 | QNTM | Quantum BioPharma Ltd. | 24.48M | -3.68% | 277,788 | - |
| 470 | ACTU | Actuate Therapeutics, Inc. | 23.93M | -0.99% | 33,890 | - |
| 471 | CALC | CalciMedica, Inc. | 23.65M | 2.59% | 9,876 | - |
| 472 | CNSY | Cerenome, Inc. | 22.51M | -11.14% | 128,200 | 4.20M |
| 473 | ALLR | Allarity Therapeutics, Inc. | 21.85M | 0.26% | 11,970 | 345.00K |
| 474 | COCP | Cocrystal Pharma, Inc. | 21.57M | 0.01% | 14,567 | 330.00K |
| 475 | ABVC | ABVC BioPharma, Inc. | 21.50M | -5.43% | 76,293 | 797.92K |
| 476 | CLRB | Cellectar Biosciences, Inc. | 20.90M | 0.58% | 9,841 | - |
| 477 | NEUP | Neuphoria Therapeutics Inc. | 20.81M | -0.52% | 1,969 | -13.27K |
| 478 | PLRZ | Polyrizon Ltd. | 20.65M | 0.46% | 17,683 | - |
| 479 | CELU | Celularity Inc. | 20.35M | 1.03% | 4,801 | 26.55M |
| 480 | MRKR | Marker Therapeutics, Inc. | 19.63M | 3.30% | 12,303 | 2.69M |
| 481 | SKYE | Skye Bioscience, Inc. | 19.43M | 10.25% | 1,433,371 | - |
| 482 | HOWL | Werewolf Therapeutics, Inc. | 19.07M | -3.06% | 107,471 | 21.00M |
| 483 | NCEL | NewcelX Ltd. | 18.84M | 4.63% | 1,577 | - |
| 484 | PLUR | Pluri Inc. | 18.34M | 6.25% | 9,361 | 1.08M |
| 485 | CYCN | Cyclerion Therapeutics, Inc. | 17.92M | 2.64% | 2,129 | 1.90M |
| 486 | TPST | Tempest Therapeutics, Inc. | 17.90M | 10.34% | 244,770 | - |
| 487 | TVRD | Tvardi Therapeutics, Inc. | 17.82M | - | 28,874 | - |
| 488 | KALA | KALA BIO, Inc. | 17.65M | 0.43% | 25,470 | - |
| 489 | LPCN | Lipocine Inc. | 17.56M | 0.95% | 4,673 | 1.57M |
| 490 | PTN | Palatin Technologies, Inc. | 17.44M | 2.30% | 1,608 | 12.88M |
| 491 | OSRH | OSR Health, Inc. | 17.28M | 55.79% | 27,564,710 | 1.81M |
| 492 | NRSN | NeuroSense Therapeutics Ltd. | 16.42M | -1.99% | 182,073 | - |
| 493 | KTTA | Pasithea Therapeutics Corp. | 16.37M | 1.96% | 88,174 | - |
| 494 | HIND | Vyome Holdings, Inc. | 15.51M | 1.34% | 1,542 | 129.73K |
| 495 | LEXX | Lexaria Bioscience Corp. | 15.20M | 1.77% | 5,255 | 194.00K |
| 496 | CTXR | Citius Pharmaceuticals, Inc. | 15.13M | -27.08% | 1,330,784 | 7.11M |
| 497 | AKTX | Akari Therapeutics, Plc | 15.11M | 2.92% | 21,383 | - |
| 498 | MLEC | Moolec Science SA | 14.96M | -0.14% | 7,049 | 7.83M |
| 499 | PASG | Passage Bio, Inc. | 14.19M | -3.92% | 1,243 | - |
| 500 | CMMB | Chemomab Therapeutics Ltd. | 13.75M | - | 23,776 | - |